Combined non-enzymatic and enzymatic reduction favors bioactivation of racemic lipoic acid: An advantage of a racemic drug?

G.Ph. Biewenga, G.R.M.M. Haenen, B.H. Groen, J.E. Biewenga, A. Bast, R. van Grondelle

Research output: Contribution to JournalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)362-366
JournalChirality
Volume9
DOIs
Publication statusPublished - 1997

Cite this